Description
"How Hacking Your Gut Bacteria Can Regulate Your Blood Sugar" features Dave Asprey and Colleen Cutcliffe (PhD), CEO of Pendulum Therapeutics, discussing the gut microbiome’s role in managing blood sugar. They explore how specific probiotics improve glucose control for Type 2 diabetes patients. The conversation highlights the microbiome’s impact on immune response, digestion, and metabolism. Cutcliffe explains how nurturing gut flora can transform disease management, offering a new approach to improving overall health and wellbeing.
How Hacking Your Gut Bacteria Can Regulate Your Blood Sugar
Guest
Colleen Cutcliffe
Category
Digestive Health, Metabolic Health, Nutrition
Tags
This episode currently does not include podcast tags related to its content. We are in the process of updating and adding relevant tags to improve accessibility and categorization.
About The Host
Dave Asprey [aka 'Father of Biohacking'] is a pioneer in biohacking and the host of The Human Upgrade podcast. He is the creator of Bulletproof coffee and founder of Upgrade Labs. As a science author, Dave has worked with top researchers and doctors to develop cutting-edge techniques that enhance human biology. His books, The Bulletproof Diet and Head Strong, were published in 2014 and 2017, respectively.
Dave Asprey [aka 'Father of Biohacking'] is a pioneer in biohacking and the host of The Human Upgrade podcast. He is the creator of Bulletproof coffee and founder of Upgrade Labs. As a science author, Dave has worked with top researchers and doctors to develop cutting-edge techniques that enhance human biology. His books, The Bulletproof Diet and Head Strong, were published in 2014 and 2017, respectively.
About The Guest
Colleen Cutcliffe (PhD) is the CEO and co-founder of Pendulum Therapeutics, a biotechnology company specializing in microbiome science. With a doctorate in Biochemistry and Molecular Biology from Johns Hopkins University, she has over 15 years of experience in academic and industry research. Pendulum Therapeutics develops evidence-based medical probiotics to address unique health needs, bridging nature and medicine to improve lives through innovative microbiome solutions.
Colleen Cutcliffe (PhD) is the CEO and co-founder of Pendulum Therapeutics, a biotechnology company specializing in microbiome science. With a doctorate in Biochemistry and Molecular Biology from Johns Hopkins University, she has over 15 years of experience in academic and industry research. Pendulum Therapeutics develops evidence-based medical probiotics to address unique health needs, bridging nature and medicine to improve lives through innovative microbiome solutions.
Support the Guest
This episode does not include any guest appearances, or information about the guests' website, Instagram, Facebook, or Twitter profiles is currently unknown to us. We’ll update this page as soon as more details become available.